Carlos González‐Alayón

Rivaroxaban to prevent complications of portal hypertension in cirrhosis: The CIRROXABAN study

Ángela Puente, Fanny Turón, Javier Marco Martínez, José Ignacio Fortea et autres

es, nl (code pays fourni par la source)

WED-175 Anemia following portal hypertension-related bleeding in liver cirrhosis: incidence and impact on prognosis

Asunción Ojeda, Marta Magaz, Idioia Agulleiro, I PASCUAL et autres

TOP-330 Prevalence and prognostic impact of sarcopenia in porto- sinusoidal vascular disorder

José Ferrusquía‐Acosta, Katharina Lampichler, Maxime Ronot, Anna Darnell et autres

GS-004 Development of portal hypertension after non-cirrhotic non-tumoral recent portal vein thrombosis (RPVT). A long-term follow-up study

Berta Bartrolí Alabau, Aurélie Plessier, F. Martinón Sánchez, Audrey Payancé et autres

Measured GFR redefined with dried-blood spot: Simplicity with reliability

Carlos González‐Alayón, Manuel Hernández‐Guerra, Sergio Luis Lima, Esteban Porrini

es (code pays fourni par la source)

Measured glomerular filtration rate predicts liver related deaths better than estimated glomerular filtration rate in advanced chronic liver disease

Carlos González‐Alayón, Manuel Hernández‐Guerra, Sergio Luis Lima, Andrea Santana-Delgado et autres

BACKGROUND & AIMS: Renal dysfunction is prevalent in advanced chronic liver disease (aCLD) and is associated to liver-related death (LRD). This makes a reliable evaluation of renal function (RF) a crucial aspect. RF can be estimated by formulas or measured by gold …

es (code pays fourni par la source)

Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter study

Valeria Pérez‐Campuzano, Pierre‐Emmanuel Rautou, Thomas Marjot, Michael Praktiknjo et autres

Background & Aims: Patients with vascular liver diseases (VLD) are at higher risk of both severe courses of COVID-19 disease and thromboembolic events. The impact of SARS-CoV-2 vaccination in patients with VLD has not been described and represents the aim of our …

es, fr, gb, de, it, at, be (code pays fourni par la source)

Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome

Marta Magaz, Héloïse Giudicelli, Juan G. Abraldeṣ, Oana Nicoară-Farcău et autres

es, fr, ca, gb, be, ch, ro, pt, in, it, de, at (code pays fourni par la source)

Comparative Study of Predictive Models for the Detection of Patients at High Risk of Inadequate Colonic Cleansing

Antonio Zebenzuy Gimeno-García, Davinia Sacramento-Luis, Marta Cámara-Suárez, María Díaz-Beunza et autres

Background: Various predictive models have been published to identify outpatients with inadequate colonic cleansing who may benefit from intensified preparations to improve colonoscopy quality. The main objective of this study was to compare the accuracy of three predictive models for identifying poor …

es (code pays fourni par la source)

Decaying kidney function during cirrhosis correlates with remodeling of distal colon aldosterone target gene expression

Natalia Serrano‐Morillas, Carlos González‐Alayón, Arianna Vastola-Mascolo, Ana Elena Rodríguez‐Rodríguez et autres

Liver cirrhosis progression significantly alters ion transporter subunit expression in the rat distal colon, a change that correlated well with declining kidney function and the severity of the disease. Our data suggest that the steroid hormone aldosterone participates in this homeostatic response …

es (code pays fourni par la source)

Porto sinusoidal vascular liver disorder: natural history and long-term outcome

Marta Magaz, Heloïse Giudicelli-Lett, Juan G. Abraldeṣ, Oana Nicoară-Farcău et autres

Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebo-controlled trial

Ángela Puente Sánchez, Fanny Turón, Javier Marco Martínez, José Ignacio Fortea et autres